Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

Share Price is delayed by 15 minutes
Get Live Data
142.00    6.80 (5.03%)
Bid:
135.00
Ask:
142.00
Spread: 7.00 (5.185%)
Market Cap: £277.29m
FORT Live PriceLast checked at - London Stock Exchange

Intraday Forterra Share Chart

Post close half year trading update

11 Jul 2023 07:00

RNS Number : 5661F
Forterra plc
11 July 2023
 

11 July 2023

 

FORTERRA PLC

 

Post close half year trading update

 

In advance of the publication of our half year results on 27 July 2023 Forterra plc (the 'Group'), a leading UK manufacturer of essential clay and concrete building products, provides this trading update for the six-month period ending 30 June 2023 (the 'period').

 

Key points

 

· Resilient H1 results broadly in line with our expectations, delivered against a backdrop of challenging trading conditions

· We expect to report H1 revenues of approximately £183m, adjusted EBITDA of approximately £30m and adjusted PBT of approximately £18m

· Progressive signs of market improvement seen through May and June, although this improvement has been less pronounced than previously anticipated

· Considering the increasingly uncertain macroeconomic outlook we now expect to deliver full year 2023 EBITDA with a more balanced H1 / H2 split, reflecting only a modest improvement in trading conditions in H2

 

H1 results

 

· Subject to review by our auditors, we expect to report revenues for the period of approximately £183m, a decrease of 18% relative to the prior year (2022: £222.8m)

· We expect to report a resilient H1 result broadly in line with management expectations, with adjusted EBITDA of approximately £30m (2022: £46.1m) and adjusted PBT of approximately £18m (2022: £37.3m)

· Whilst market conditions remain competitive, our selling prices have remained firm and our cost base stable

· As planned, we have rebuilt our inventory, with stock levels increasing by approximately £30m in the period, leaving us well placed to deliver the service levels our customers expect

· We have maintained a strong and flexible balance sheet and expect to report a period end net debt before leases of approximately £50m (2022 year end: £5.9m) which is below 1x adjusted EBITDA on a LTM basis

 

Management actions

 

· In response to the challenging market conditions, and with our brick production capacity increasing with the opening of the new Desford factory, as previously announced, we have mothballed our Howley Park brick factory and implemented other production reductions which will reduce our fixed costs by around £10m on an annualised basis

· In addition, we are consulting with affected individuals on a restructuring of our commercial and support functions, aligning them to anticipated demand, which we expect to save approximately £3m annually

· The demand for our products in H2 will influence our production decisions. Having replenished our inventories in H1 we expect to limit our inventory growth in H2 and will continue to take appropriate action to ensure our output is aligned to demand

· Our strategy remains to maximise the ramp up of production at the new Desford factory, such that we can benefit from the market leading efficiencies it will offer once fully commissioned

 

Market backdrop and outlook

 

· UK brick industry despatches, as published by the Department of Business and Trade, were 31% adverse to the prior year in the five months to May 2023, with the month of May showing signs of an improving trend which is further evidenced by our own despatches for June, albeit this improvement is less pronounced than previously anticipated

· Encouragingly, imports of bricks to the UK have fallen significantly, decreasing 44% relative to 2022 in the four months to April, although they still remain high as a proportion of overall demand

· Although customer inventory reduction has been more prolonged than anticipated, we still expect this to ease in H2

· Demand for our products for the rest of the year remains subject to significant uncertainty with rising interest rates widely expected to adversely impact the demand for new homes for the foreseeable future

· Contrary to the wider macroeconomic backdrop, our precast flooring business, which can be regarded as a leading indicator for future brick and block demand is performing strongly, with despatches presently only 20% below prior year levels with current order intake running ahead of this

· As set out at the start of the year, our expectations for 2023 were based upon an underlying fall in full year market demand of 20% relative to 2022, with a slow start to the year followed by a meaningful recovery strengthening into H2 

· However, we are now assuming only a modest improvement in trading conditions, and therefore expect to deliver full year EBITDA with a more balanced H1 / H2 split

· The impacts of greater borrowing, inventory build, and rising interest rates are also expected to drive an increase in our financing costs

· Notwithstanding a weaker market in the short-term, looking further ahead, the Board remains confident that the Group remains well positioned to benefit from attractive market fundamentals of a shortage of UK housing supply, a shortfall of domestic brick production capacity and cross-party political support for increasing housing supply

 

This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) No 596/2014.

 

ENQUIRIES

 

Forterra plc +44 1604 707 600

Neil Ash, Chief Executive Officer

Ben Guyatt, Chief Financial Officer

 

FTI Consulting +44 203 727 1340

Richard Mountain / Nick Hasell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFZGMNRGRGFZM
Date   Source Headline
13th Mar 20209:55 amRNSHolding(s) in Company
13th Mar 20209:51 amRNSDirector/PDMR Shareholding
10th Mar 20207:00 amRNS2019 FULL YEAR RESULTS
3rd Mar 20207:00 amRNSEmployee Benefit Trust Share Purchase
24th Feb 20209:23 amRNSHolding(s) in Company
6th Feb 202010:59 amRNSEmployee Benefit Trust Share Purchase
30th Jan 20202:10 pmRNSHolding(s) in Company
28th Jan 20203:47 pmRNSHolding(s) in Company
22nd Jan 20207:00 amRNSTrading Update
16th Jan 20207:00 amRNSHolding(s) in Company
6th Jan 20204:51 pmRNSEmployee Benefit Trust Share Purchase
6th Jan 202011:01 amRNSHolding(s) in Company
2nd Jan 20203:00 pmRNSCompany Secretary Change
2nd Jan 20207:00 amRNSHolding(s) in Company
2nd Jan 20207:00 amRNSHolding(s) in Company
23rd Dec 20194:36 pmRNSHolding(s) in Company
17th Dec 20198:57 amRNSDirector/PDMR Shareholding
16th Dec 20195:42 pmRNSHolding(s) in Company
11th Dec 20197:00 amRNSDirector/PDMR Shareholding
10th Dec 20197:00 amRNSBoard Changes
6th Dec 201910:46 amRNSDirector/PDMR Shareholding
4th Dec 201912:01 pmRNSEmployee Benefit Trust Share Purchase
3rd Dec 20197:00 amRNSDirector/PDMR Shareholding
5th Nov 201912:38 pmRNSEmployee Benefit Trust Share Purchase
24th Oct 20199:51 amRNSHolding(s) in Company
22nd Oct 20197:00 amRNSTrading update
7th Oct 20192:03 pmRNSHolding(s) in Company
4th Oct 20192:09 pmRNSGrant of Options under 2018 SAYE Scheme
2nd Oct 20193:15 pmRNSEmployee Benefit Trust Share Purchase
26th Sep 20194:50 pmRNSEmployee Benefit Trust Share Purchase
9th Sep 20195:34 pmRNSDirector/PDMR Shareholding
4th Sep 20198:51 amRNSHolding(s) in Company
30th Jul 20197:00 amRNS2019 HALF YEAR RESULTS
4th Jul 201911:49 amRNSEmployee Benefit Trust Share Purchase
5th Jun 20199:20 amRNSEmployee Benefit Trust Share Purchase
20th May 20191:57 pmRNSResult of AGM
20th May 20197:00 amRNSAGM Trading Update
10th May 20193:08 pmRNSDirector/PDMR Shareholding
3rd May 20199:00 amRNSEmployee Benefit Trust Share Purchase
5th Apr 20192:50 pmRNSDirector/PDMR Shareholding
5th Apr 20192:49 pmRNSEmployee Benefit Trust Share Purchase
5th Apr 20191:21 pmRNSAnnual Report & Accounts 2018 and Notice of AGM
2nd Apr 20193:58 pmRNSDirector/PDMR Shareholding
29th Mar 20199:11 amRNSGrant under Performance Share Plan
29th Mar 20199:10 amRNSGrant under Deferred Annual Bonus Plan
14th Mar 201911:28 amRNSEmployee Benefit Trust Share Purchase
12th Mar 201910:00 amRNSEmployee Benefit Trust Share Purchase
5th Mar 20198:45 amRNSEmployee Benefit Trust Share Purchase
8th Feb 20199:00 amRNSDirector Declaration
8th Feb 20197:00 amRNSAppointment of new Independent NED

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.